Rabies Diagnostics Market Trends, Size and Forecast (2021-2031)
The Rabies Diagnostics Market is expected to register a CAGR of 4.6% from 2023 to 2031, with a market size expanding from US$ XX million in 2023 to US$ XX Million by 2031.
The Rabies Diagnostics Market report covers analysis By Diagnosis (Fluorescent Antibody Test (FAT), Immunohistochemical test, Amplification methods, Histologic examination, Serology tests); Technology (Immunohistochemistry, Chromatography techniques, PCR, Others), and Geography (North America, Europe, Asia Pacific, and South and Central America). The global analysis is further broken-down at regional level and major countries. The Report Offers the Value in USD for the above analysis and segments.
Purpose of the ReportThe report Rabies Diagnostics Market by The Insight Partners aims to describe the present landscape and future growth, top driving factors, challenges, and opportunities. This will provide insights to various business stakeholders, such as:
- Technology Providers/Manufacturers: To understand the evolving market dynamics and know the potential growth opportunities, enabling them to make informed strategic decisions.
- Investors: To conduct a comprehensive trend analysis regarding the market growth rate, market financial projections, and opportunities that exist across the value chain.
- Regulatory bodies: To regulate policies and police activities in the market with the aim of minimizing abuse, preserving investor trust and confidence, and upholding the integrity and stability of the market.
Rabies Diagnostics Market Segmentation
Diagnosis- Fluorescent Antibody Test
- Immunohistochemical test
- Amplification methods
- Histologic examination
- Serology tests
- Immunohistochemistry
- Chromatography techniques
- PCR
- Others
Strategic Insights
Rabies Diagnostics Market Growth Drivers- Rising Incidence of Rabies Cases:
The increasing number of rabies cases globally, particularly in developing countries where access to healthcare may be limited, is driving demand for effective diagnostic tools to detect the disease early.
- Government Initiatives and Awareness Campaigns:
Governments and non-governmental organizations are increasing their efforts to control rabies through vaccination campaigns and awareness programs, which has spurred the need for efficient diagnostic solutions. - Technological Advancements in Diagnostic Methods:
The development of more accurate, rapid, and less invasive diagnostic techniques is fueling the growth of the rabies diagnostics market. PCR-based tests, rapid diagnostic tests (RDTs), and ELISA are examples of advanced diagnostic methods making a significant impact.
- Point-of-Care Testing:
There is an increasing focus on point-of-care (POC) testing for rabies, where diagnostic tests can be conducted outside of traditional laboratory settings, enabling quicker diagnosis and timely treatment.
- Integration of Molecular Diagnostics:
Molecular diagnostics, such as PCR and RT-PCR, are gaining popularity due to their ability to detect the rabies virus with high accuracy and sensitivity. This trend is expected to continue as molecular technologies become more accessible.
- Collaboration with Veterinary Clinics and Animal Hospitals:
Diagnostic companies are partnering with veterinary clinics and animal hospitals to offer rabies testing services, increasing awareness and accessibility for early diagnosis and treatment in animals, which is critical to preventing transmission to humans.
- Growth in Veterinary Diagnostics:
The growth of veterinary diagnostics offers a significant opportunity for the rabies diagnostics market, as early detection in animals plays a crucial role in preventing the spread of the disease to humans.
- Development of Rapid Diagnostic Kits:
There is an opportunity for the development of rapid diagnostic kits for rabies that can be used in the field or in remote locations, improving access to diagnostic solutions in underserved regions.
- Government Funding for Disease Control Programs:
Continued government support for rabies control programs, including funding for diagnostic tools and mass vaccination efforts, presents opportunities for growth in the market.
Market Report Scope
Key Selling Points
- Comprehensive Coverage: The report comprehensively covers the analysis of products, services, types, and end users of the Rabies Diagnostics Market, providing a holistic landscape.
- Expert Analysis: The report is compiled based on the in-depth understanding of industry experts and analysts.
- Up-to-date Information: The report assures business relevance due to its coverage of recent information and data trends.
- Customization Options: This report can be customized to cater to specific client requirements and suit the business strategies aptly.
The research report on the Rabies Diagnostics Market can, therefore, help spearhead the trail of decoding and understanding the industry scenario and growth prospects. Although there can be a few valid concerns, the overall benefits of this report tend to outweigh the disadvantages.
REGIONAL FRAMEWORK
Have a question?
Mrinal
Mrinal will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.
Speak to Analyst
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
This text is related
to segments covered.
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
This text is related
to country scope.
Frequently Asked Questions
The Rabies Diagnostics Market is estimated to witness a CAGR of 4.6% from 2023 to 2031.
The major factors driving the market are: Rising incidence of rabies, Advances in diagnostic technologies, Government initiatives and awareness campaigns
Key future trends in this market are - Government Initiatives, Rapid Diagnostic Tools, International Travel Growth
Key companies of this market are: MyBioSource.com, BioNote, Inc., Express Biotech International Inc., Abbexa Ltd, Demeditec Diagnostics GmbH, Merck KGaA, Creative Diagnostics, Bio-Rad Laboratories, Inc, Aviva Systems Biology Corporation, Norgen Biotek Corp.
The report can be delivered in PDF/PPT format; we can also share excel dataset based on the request.
Some of the customization options available based on request are additional 3-5 company profiles and country-specific analysis of 3-5 countries of your choice. Customizations are to be requested/discussed before making final order confirmation, as our team would review the same and check the feasibility.
1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Rabies Diagnostics Market - By Diagnosis
1.3.2 Rabies Diagnostics Market - By Technology
1.3.3 Rabies Diagnostics Market - By Region
1.3.3.1 By Country
2. KEY TAKEAWAYS
3. RESEARCH METHODOLOGY
4. RABIES DIAGNOSTICS MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS
5. RABIES DIAGNOSTICS MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS, RESTRAINTS & EXPECTED INFLUENCE OF COVID-19 PANDEMIC
6. RABIES DIAGNOSTICS MARKET - GLOBAL MARKET ANALYSIS
6.1. RABIES DIAGNOSTICS - GLOBAL MARKET OVERVIEW
6.2. RABIES DIAGNOSTICS - GLOBAL MARKET AND FORECAST TO 2028
6.3. MARKET POSITIONING/MARKET SHARE
7. RABIES DIAGNOSTICS MARKET - REVENUE AND FORECASTS TO 2028 - DIAGNOSIS
7.1. OVERVIEW
7.2. DIAGNOSIS MARKET FORECASTS AND ANALYSIS
7.3. FLUORESCENT ANTIBODY TEST (FAT)
7.3.1. Overview
7.3.2. Fluorescent Antibody Test (FAT) Market Forecast and Analysis
7.4. IMMUNOHISTOCHEMICAL TEST
7.4.1. Overview
7.4.2. Immunohistochemical test Market Forecast and Analysis
7.5. AMPLIFICATION METHODS
7.5.1. Overview
7.5.2. Amplification methods Market Forecast and Analysis
7.6. HISTOLOGIC EXAMINATION
7.6.1. Overview
7.6.2. Histologic examination Market Forecast and Analysis
7.7. SEROLOGY TESTS
7.7.1. Overview
7.7.2. Serology tests Market Forecast and Analysis
8. RABIES DIAGNOSTICS MARKET - REVENUE AND FORECASTS TO 2028 - TECHNOLOGY
8.1. OVERVIEW
8.2. TECHNOLOGY MARKET FORECASTS AND ANALYSIS
8.3. IMMUNOHISTOCHEMISTRY
8.3.1. Overview
8.3.2. Immunohistochemistry Market Forecast and Analysis
8.4. CHROMATOGRAPHY TECHNIQUES
8.4.1. Overview
8.4.2. Chromatography techniques Market Forecast and Analysis
8.5. PCR
8.5.1. Overview
8.5.2. PCR Market Forecast and Analysis
8.6. OTHERS
8.6.1. Overview
8.6.2. Others Market Forecast and Analysis
9. RABIES DIAGNOSTICS MARKET REVENUE AND FORECASTS TO 2028 - GEOGRAPHICAL ANALYSIS
9.1. NORTH AMERICA
9.1.1 North America Rabies Diagnostics Market Overview
9.1.2 North America Rabies Diagnostics Market Forecasts and Analysis
9.1.3 North America Rabies Diagnostics Market Forecasts and Analysis - By Diagnosis
9.1.4 North America Rabies Diagnostics Market Forecasts and Analysis - By Technology
9.1.5 North America Rabies Diagnostics Market Forecasts and Analysis - By Countries
9.1.5.1 United States Rabies Diagnostics Market
9.1.5.1.1 United States Rabies Diagnostics Market by Diagnosis
9.1.5.1.2 United States Rabies Diagnostics Market by Technology
9.1.5.2 Canada Rabies Diagnostics Market
9.1.5.2.1 Canada Rabies Diagnostics Market by Diagnosis
9.1.5.2.2 Canada Rabies Diagnostics Market by Technology
9.1.5.3 Mexico Rabies Diagnostics Market
9.1.5.3.1 Mexico Rabies Diagnostics Market by Diagnosis
9.1.5.3.2 Mexico Rabies Diagnostics Market by Technology
9.1.5.4 US Rabies Diagnostics Market
9.1.5.4.1 US Rabies Diagnostics Market by Diagnosis
9.1.5.4.2 US Rabies Diagnostics Market by Technology
9.2. EUROPE
9.2.1 Europe Rabies Diagnostics Market Overview
9.2.2 Europe Rabies Diagnostics Market Forecasts and Analysis
9.2.3 Europe Rabies Diagnostics Market Forecasts and Analysis - By Diagnosis
9.2.4 Europe Rabies Diagnostics Market Forecasts and Analysis - By Technology
9.2.5 Europe Rabies Diagnostics Market Forecasts and Analysis - By Countries
9.2.5.1 Germany Rabies Diagnostics Market
9.2.5.1.1 Germany Rabies Diagnostics Market by Diagnosis
9.2.5.1.2 Germany Rabies Diagnostics Market by Technology
9.2.5.2 France Rabies Diagnostics Market
9.2.5.2.1 France Rabies Diagnostics Market by Diagnosis
9.2.5.2.2 France Rabies Diagnostics Market by Technology
9.2.5.3 Italy Rabies Diagnostics Market
9.2.5.3.1 Italy Rabies Diagnostics Market by Diagnosis
9.2.5.3.2 Italy Rabies Diagnostics Market by Technology
9.2.5.4 Spain Rabies Diagnostics Market
9.2.5.4.1 Spain Rabies Diagnostics Market by Diagnosis
9.2.5.4.2 Spain Rabies Diagnostics Market by Technology
9.2.5.5 United Kingdom Rabies Diagnostics Market
9.2.5.5.1 United Kingdom Rabies Diagnostics Market by Diagnosis
9.2.5.5.2 United Kingdom Rabies Diagnostics Market by Technology
9.3. ASIA-PACIFIC
9.3.1 Asia-Pacific Rabies Diagnostics Market Overview
9.3.2 Asia-Pacific Rabies Diagnostics Market Forecasts and Analysis
9.3.3 Asia-Pacific Rabies Diagnostics Market Forecasts and Analysis - By Diagnosis
9.3.4 Asia-Pacific Rabies Diagnostics Market Forecasts and Analysis - By Technology
9.3.5 Asia-Pacific Rabies Diagnostics Market Forecasts and Analysis - By Countries
9.3.5.1 Australia Rabies Diagnostics Market
9.3.5.1.1 Australia Rabies Diagnostics Market by Diagnosis
9.3.5.1.2 Australia Rabies Diagnostics Market by Technology
9.3.5.2 China Rabies Diagnostics Market
9.3.5.2.1 China Rabies Diagnostics Market by Diagnosis
9.3.5.2.2 China Rabies Diagnostics Market by Technology
9.3.5.3 India Rabies Diagnostics Market
9.3.5.3.1 India Rabies Diagnostics Market by Diagnosis
9.3.5.3.2 India Rabies Diagnostics Market by Technology
9.3.5.4 Japan Rabies Diagnostics Market
9.3.5.4.1 Japan Rabies Diagnostics Market by Diagnosis
9.3.5.4.2 Japan Rabies Diagnostics Market by Technology
9.4. MIDDLE EAST AND AFRICA
9.4.1 Middle East and Africa Rabies Diagnostics Market Overview
9.4.2 Middle East and Africa Rabies Diagnostics Market Forecasts and Analysis
9.4.3 Middle East and Africa Rabies Diagnostics Market Forecasts and Analysis - By Diagnosis
9.4.4 Middle East and Africa Rabies Diagnostics Market Forecasts and Analysis - By Technology
9.4.5 Middle East and Africa Rabies Diagnostics Market Forecasts and Analysis - By Countries
9.4.5.1 South Africa Rabies Diagnostics Market
9.4.5.1.1 South Africa Rabies Diagnostics Market by Diagnosis
9.4.5.1.2 South Africa Rabies Diagnostics Market by Technology
9.4.5.2 Saudi Arabia Rabies Diagnostics Market
9.4.5.2.1 Saudi Arabia Rabies Diagnostics Market by Diagnosis
9.4.5.2.2 Saudi Arabia Rabies Diagnostics Market by Technology
9.4.5.3 U.A.E Rabies Diagnostics Market
9.4.5.3.1 U.A.E Rabies Diagnostics Market by Diagnosis
9.4.5.3.2 U.A.E Rabies Diagnostics Market by Technology
9.5. SOUTH AND CENTRAL AMERICA
9.5.1 South and Central America Rabies Diagnostics Market Overview
9.5.2 South and Central America Rabies Diagnostics Market Forecasts and Analysis
9.5.3 South and Central America Rabies Diagnostics Market Forecasts and Analysis - By Diagnosis
9.5.4 South and Central America Rabies Diagnostics Market Forecasts and Analysis - By Technology
9.5.5 South and Central America Rabies Diagnostics Market Forecasts and Analysis - By Countries
9.5.5.1 Brazil Rabies Diagnostics Market
9.5.5.1.1 Brazil Rabies Diagnostics Market by Diagnosis
9.5.5.1.2 Brazil Rabies Diagnostics Market by Technology
9.5.5.2 Argentina Rabies Diagnostics Market
9.5.5.2.1 Argentina Rabies Diagnostics Market by Diagnosis
9.5.5.2.2 Argentina Rabies Diagnostics Market by Technology
10. INDUSTRY LANDSCAPE
10.1. MERGERS AND ACQUISITIONS
10.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
10.3. NEW PRODUCT LAUNCHES
10.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
11. RABIES DIAGNOSTICS MARKET, KEY COMPANY PROFILES
11.1. MYBIOSOURCE.COM
11.1.1. Key Facts
11.1.2. Business Description
11.1.3. Products and Services
11.1.4. Financial Overview
11.1.5. SWOT Analysis
11.1.6. Key Developments
11.2. BIONOTE, INC
11.2.1. Key Facts
11.2.2. Business Description
11.2.3. Products and Services
11.2.4. Financial Overview
11.2.5. SWOT Analysis
11.2.6. Key Developments
11.3. EXPRESS BIOTECH INTERNATIONAL INC.
11.3.1. Key Facts
11.3.2. Business Description
11.3.3. Products and Services
11.3.4. Financial Overview
11.3.5. SWOT Analysis
11.3.6. Key Developments
11.4. ABBEXA LTD
11.4.1. Key Facts
11.4.2. Business Description
11.4.3. Products and Services
11.4.4. Financial Overview
11.4.5. SWOT Analysis
11.4.6. Key Developments
11.5. DEMEDITEC DIAGNOSTICS GMBH
11.5.1. Key Facts
11.5.2. Business Description
11.5.3. Products and Services
11.5.4. Financial Overview
11.5.5. SWOT Analysis
11.5.6. Key Developments
11.6. MERCK KGAA
11.6.1. Key Facts
11.6.2. Business Description
11.6.3. Products and Services
11.6.4. Financial Overview
11.6.5. SWOT Analysis
11.6.6. Key Developments
11.7. CREATIVE DIAGNOSTICS
11.7.1. Key Facts
11.7.2. Business Description
11.7.3. Products and Services
11.7.4. Financial Overview
11.7.5. SWOT Analysis
11.7.6. Key Developments
11.8. BIO-RAD LABORATORIES, INC
11.8.1. Key Facts
11.8.2. Business Description
11.8.3. Products and Services
11.8.4. Financial Overview
11.8.5. SWOT Analysis
11.8.6. Key Developments
11.9. AVIVA SYSTEMS BIOLOGY CORPORATION
11.9.1. Key Facts
11.9.2. Business Description
11.9.3. Products and Services
11.9.4. Financial Overview
11.9.5. SWOT Analysis
11.9.6. Key Developments
11.10. NORGEN BIOTEK CORP.
11.10.1. Key Facts
11.10.2. Business Description
11.10.3. Products and Services
11.10.4. Financial Overview
11.10.5. SWOT Analysis
11.10.6. Key Developments
12. APPENDIX
12.1. ABOUT THE INSIGHT PARTNERS
12.2. GLOSSARY OF TERMS
- MyBioSource.com.
- BioNote, Inc.
- Express Biotech International Inc.
- Abbexa Ltd
- Demeditec Diagnostics GmbH
- Merck KGaA
- Creative Diagnostics
- Bio-Rad Laboratories, Inc
- Aviva Systems Biology Corporation
- Norgen Biotek Corp.
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published many reports and advised several clients across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organizations are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in the last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/Sales Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- 3.1 Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- 3.2 Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- 3.3 Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- 3.4 Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.
Get Free Sample For